Interventional Lung Solutions Market Report 2026

Interventional Lung Solutions Market Overview

• Interventional Lung Solutions market size has reached to $2.47 billion in 2025 • Expected to grow to $3.66 billion in 2030 at a compound annual growth rate (CAGR) of 8.1% • Growth Driver: Increasing Prevalence Of Respiratory Diseases The Growth Of The Market Due To Rising Air Pollution And Chronic Pulmonary Conditions • Market Trend: Innovative Robotic Technologies Revolutionize Interventional Lung Solutions And Early Lung Cancer Detection • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Interventional Lung Solutions Market?

Interventional lung solutions refer to minimally invasive procedures and technologies used to diagnose and treat lung conditions such as chronic obstructive pulmonary disease (COPD), lung cancer, and emphysema. These solutions often include bronchoscopy interventions, endobronchial valves, and image-guided therapies that improve lung function and patient outcomes. The main product types of interventional lung solutions are bronchoscopes, endobronchial ultrasound needles, pleuroscopes, airway stents, and other product types. Bronchoscopes are medical instruments used for visualizing and examining the airways and lungs, typically inserted through the nose or mouth to diagnose and treat respiratory conditions. Technologies associated with bronchoscopes include robotic surgery, laser therapy, and electromagnetic navigation bronchoscopy. The various procedures include bronchoscopy, thoracoscopy, pleuroscopy, and others. The multiple applications involved are lung cancer treatment, chronic obstructive pulmonary disease, and sleep apnea treatment and are used by several end users, such as hospitals, ambulatory surgical centers, specialty clinics, and additional healthcare settings.

What Is The Interventional Lung Solutions Market Growth Forecast?

The interventional lung solutions market size is expected to see strong growth in the next few years. It will grow to $3.66 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to growth in aging population with respiratory diseases, increasing adoption of robotic-assisted interventions, expansion of outpatient pulmonary procedures, rising focus on early lung cancer diagnosis, technological advancements in navigation bronchoscopy. Major trends in the forecast period include rising adoption of minimally invasive pulmonary procedures, increasing use of robotic bronchoscopy systems, growing demand for lung volume reduction devices, expansion of image-guided interventional lung therapies, increasing preference for disposable bronchoscopes.

Global Interventional Lung Solutions Market Segmentation

1) By Product Type: Bronchoscopes, Endobronchial Ultrasound Needles, Pleuroscopes, Airway Stents, Other Product Types 2) By Technology: Robotic Surgery, Laser Therapy, Electromagnetic Navigation Bronchoscopy 3) By Procedure: Bronchoscopy, Thoracoscopy, Pleuroscopy, Other Procedures 4) By Application: Lung Cancer Treatment, Chronic Obstructive Pulmonary Disease 5) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users Subsegments: 1) BY Bronchoscopes: Flexible Bronchoscopes, Rigid Bronchoscopes, Disposable Bronchoscopes 2) By Endobronchial Ultrasound Needles: Transbronchial Aspiration Needles, Biopsy Needles 3) By Pleuroscopes: Flexible Pleuroscopes, Semi-Rigid Pleuroscopes 4) By Airway Stents: Metallic Stents, Silicone Stents, Hybrid Stents 5) By Other Product Types: Bronchial Thermoplasty Devices, Lung Volume Reduction Devices, Electromagnetic Navigation Systems, Cryotherapy And Ablation Devices

What Is The Driver Of The Interventional Lung Solutions Market?

The increasing prevalence of respiratory diseases is expected to propel the growth of the interventional lung solutions market going forward. Respiratory diseases refer to a group of medical conditions that affect the lungs and airways, making it difficult to breathe and disrupting normal respiratory function. The increasing prevalence of respiratory diseases is due to rising air pollution levels, which contribute to chronic exposure to harmful airborne particles and irritants. Interventional lung solutions help manage respiratory diseases by providing minimally invasive procedures that improve lung function and reduce symptoms in patients with chronic pulmonary conditions. For instance, in May 2025, according to the BioMed Central Ltd, a UK-based journal website, the global prevalence of chronic obstructive pulmonary disease is estimated at 10.3%, and the number of people living with the disease is projected to reach 600 million by 2050. Asthma currently affects approximately 262 million individuals worldwide. Therefore, the increasing prevalence of respiratory diseases drives the interventional lung solutions industry.

Key Players In The Global Interventional Lung Solutions Market

Major companies operating in the interventional lung solutions market are Johnson and Johnson, Siemens AG, Medtronic plc, FUJIFILM Holdings Corporation, GE Healthcare Technologies Inc., Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc., Smiths Medical Inc., Cook Medical Inc., Merit Medical Systems Inc., Penumbra Inc., Vygon SA, AngioDynamics Inc., Vapotherm Inc., Pulmonx Corporation, Broncus Medical Inc., Thirona B.V., Body Vision Medical Ltd., EndoMed Systems GmbH

Global Interventional Lung Solutions Market Trends and Insights

Major companies operating in the interventional lung solutions market are focusing on developing innovative technologies, such as the Ion Endoluminal System, to improve the accuracy of lung cancer diagnostics, enable minimally invasive procedures, and enhance patient outcomes through advanced navigation and biopsy capabilities. The Ion Endoluminal System is a robotic-assisted platform designed for minimally invasive lung procedures, enabling precise airway navigation to reach small or hard-to-access lung nodules. For instance, in April 2024, H. Lee Moffitt Cancer Center and Research Institute Foundation Inc., a US-based non-profit institution, launched a new Ion Robotic Bronchoscopy platform, enhancing their interventional pulmonology program with advanced fiber-optic technology and a minimally invasive catheter system. This technology uses fiber optics and the smallest catheter on the market to reach all areas of the lung. This platform features an ultra-thin, highly maneuverable catheter with 180° articulation, integrated real-time vision, and shape-sensing technology, enabling precise navigation and biopsy of hard-to-reach peripheral lung nodules. This system provides unprecedented stability and accuracy for tissue sampling, allowing physicians to reach all 18 lung segments and improving early lung cancer detection.

What Are Latest Mergers And Acquisitions In The Interventional Lung Solutions Market?

In February 2025, Stryker Corporation, a US-based medical device company, acquired Inari Medical Inc. for an undisclosed sum. With this acquisition, Stryker aims to enhance its interventional endovascular portfolio by incorporating innovative, thrombolytic-free solutions for venous thromboembolism (VTE), including pulmonary embolism and deep vein thrombosis treatments. Inari Medical Inc. is a US-based company that provides interventional solutions for pulmonary conditions, particularly focusing on treating pulmonary embolism (PE).

Regional Insights

North America was the largest region in the interventional lung solutions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Interventional Lung Solutions Market?

The interventional lung solutions market consists of revenues earned by entities by providing services such as endobronchial valve placement, navigational bronchoscopy, lung volume reduction, and airway stenting. The market value includes the value of related goods sold by the service provider or included within the service offering. The interventional lung solutions market also consists of sales of products including bronchial thermoplasty devices, cryotherapy devices, bronchial stents, and biopsy forceps. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Interventional Lung Solutions Market Report 2026?

The interventional lung solutions market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the interventional lung solutions industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.